| Mr Jacob Ryan Griffith, | |
|
9125 Cross Park Dr Ste 200, Knoxville, TN 37923-4563 | |
| (865) 632-5900 | |
| Not Available |
| Full Name | Mr Jacob Ryan Griffith |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 8 Years |
| Location | 9125 Cross Park Dr Ste 200, Knoxville, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023553872 | NPI | - | NPPES |
| Q030515 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkwest Medical Center | Knoxville, TN | Hospital |
| Mercyone North Iowa Medical Center | Mason city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| East Tennessee Cardiovascular Surgery Group Pc | 6608934203 | 19 |
| North Iowa Mercy Clinics | 7810809076 | 242 |
News Archive
Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, announced today the availability of the new PINPOINT Rx™ system. Combining advanced spectroscopy hardware technology, analytical software and internal databases, PINPOINT Rx™ captures the spectral signature of a prescription drug and checks this signature against a known database.
In 2012, about 28,000 new cases of cancer in men (3.5%) and 72,000 in women (9.5%) were due to overweight or obesity in the United States alone. There is an urgent need for research that focuses on the cancer-promoting effects of obesity as it's the leading preventable cause of cancer for women and the second for men.
The incidence of infective endocarditis did not increase after American guidelines for antibiotic use before dental procedures were updated in 2007, a report in Circulation shows.
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone - the hormone that fuels prostate-cancer growth - via surgical castration (orchiectomy) or medical castration with testosterone-blocking drugs. While such therapy buys time for patients, it is not a cure, as inevitably the cancer becomes resistant to the androgen deprivation and continues to grow.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jacob Ryan Griffith, 9125 Cross Park Dr Ste 200, Knoxville, TN 37923-4563 Ph: (865) 632-5900 | Mr Jacob Ryan Griffith, 9125 Cross Park Dr Ste 200, Knoxville, TN 37923-4563 Ph: (865) 632-5900 |
News Archive
Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, announced today the availability of the new PINPOINT Rx™ system. Combining advanced spectroscopy hardware technology, analytical software and internal databases, PINPOINT Rx™ captures the spectral signature of a prescription drug and checks this signature against a known database.
In 2012, about 28,000 new cases of cancer in men (3.5%) and 72,000 in women (9.5%) were due to overweight or obesity in the United States alone. There is an urgent need for research that focuses on the cancer-promoting effects of obesity as it's the leading preventable cause of cancer for women and the second for men.
The incidence of infective endocarditis did not increase after American guidelines for antibiotic use before dental procedures were updated in 2007, a report in Circulation shows.
For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone - the hormone that fuels prostate-cancer growth - via surgical castration (orchiectomy) or medical castration with testosterone-blocking drugs. While such therapy buys time for patients, it is not a cure, as inevitably the cancer becomes resistant to the androgen deprivation and continues to grow.
› Verified 1 days ago
Michael Patrick Flynn, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 501 20th St Ste 503, Knoxville, TN 37916 Phone: 865-331-4321 Fax: 865-331-4320 | |
Dakotah Asher, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4629 Mill Branch Ln, Knoxville, TN 37938 Phone: 865-201-1756 Fax: 865-922-1659 | |
Matthew Cox, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 280 Fort Sanders West Blvd Ste 101, Knoxville, TN 37922 Phone: 865-539-0270 | |
Jess Lee Stockton, Physician Assistant Medicare: Medicare Enrolled Practice Location: 123 Fox Rd, Knoxville, TN 37922 Phone: 865-342-5823 | |
Briana Roberts, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2001 Laurel Ave Ste 204, Knoxville, TN 37916 Phone: 865-673-0288 | |
Mr. Matthew C Wilks, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4319 Papermill Dr, Knoxville, TN 37909 Phone: 865-470-4127 Fax: 951-257-0143 | |
Cynthia E. Simmons, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 7211 Wellington Dr, Suite 101, Knoxville, TN 37919 Phone: 865-558-9822 |